AMPE - Ampio Pharmaceuticals, Inc.

NYSE American - NYSE American Delayed Price. Currency in USD
-0.15 (-6.44%)
At close: 4:00PM EST
Stock chart is not supported by your current browser
Previous Close2.33
Bid0.00 x 0
Ask0.00 x 0
Day's Range2.10 - 2.40
52 Week Range0.38 - 2.84
Avg. Volume1,307,485
Market Cap165.553M
PE Ratio (TTM)N/A
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target EstN/A
Trade prices are not sourced from all markets
  • SmarterAnalyst2 days ago

    Ampio Pharmaceuticals Inc (AMPE) Rallies as Knee Osteoarthritis Drug Findings Cheer

    Case in point: Ampio Pharmaceuticals Inc (NYSE:AMPE), whose shares are jumping nearly 50% in Thursday trading session. The biopharmaceutical company reported that its knee osteoarthritis drug Ampion met its primary endpoint in Phase 3 clinical trial. Specifically, 71% of Ampion treated patients met OMERACT-OARSI responder criteria, which exceeds the physician reported threshold of 30% for a meaningful treatment in severe osteoarthritis of the knee.

  • We're sorry this is all we were able to find about this topic.